Welcome to our dedicated page for CACI INTERNATIONAL /DE/ SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CACI INTERNATIONAL /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CACI INTERNATIONAL /DE/'s regulatory disclosures and financial reporting.
CACI International director Philip O. Nolan reported the vesting and conversion of 84 Restricted Stock Units into 84 shares of CACI common stock on January 14, 2026. The Form 4 shows this as a transaction with no exercise price. These RSUs are part of a 338-unit grant awarded on October 17, 2025, which is scheduled to vest in four installments through October 11, 2026. After this vesting event, Nolan directly holds 2,153 shares of CACI common stock and 254 RSUs, reflecting his ongoing equity-based compensation as a director.
CACI International director Charles L. Szews reported the vesting of previously granted equity awards. On January 14, 2026, 84 Restricted Stock Units (RSUs) that were granted on October 17, 2025 vested and were converted into 84 shares of CACI common stock at an exercise price of $0.00 per share.
After this transaction, Szews directly owns 415 shares of CACI common stock and 254 RSUs, which are scheduled to vest later under the original grant of 338 RSUs. The remaining RSUs are expected to vest in three additional installments on April 14, 2026, July 13, 2026, and October 11, 2026.
CACI International director Scott C. Morrison reported the vesting and conversion of restricted stock units into common shares. On January 14, 2026, 84 Restricted Stock Units vested and were converted into 84 shares of CACI common stock at a price of $0.00 per share, reported with transaction code "M". After this transaction, Morrison directly owned 415 shares of CACI common stock and 254 Restricted Stock Units. These RSUs are part of a 338-unit grant made on October 17, 2025 that vests in four installments through October 11, 2026.
CACI International director Susan M. Gordon reported a routine equity compensation vesting. On January 14, 2026, 84 Restricted Stock Units (RSUs) previously granted to her converted into CACI common stock at an exercise price of $0 per share. These RSUs are part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four installments through October 11, 2026.
Following this transaction, Gordon directly beneficially owned 2,821 shares of CACI common stock and 254 RSUs, reflecting ongoing board compensation rather than an open-market purchase or sale.
CACI International director Stanton D. Sloane reported the vesting of 84 Restricted Stock Units (RSUs) into 84 shares of CACI common stock on January 14, 2026, at an exercise price of $0 per share. After this transaction, he beneficially owned 943 shares of CACI common stock and 254 RSUs directly.
These RSUs are part of a 338-unit grant awarded on October 17, 2025, with a scheduled vesting of 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Lisa Disbrow reported equity awards tied to her board service. On January 14, 2026, 123 Restricted Stock Units (RSUs) vested and were settled into 123 shares of CACI common stock, leaving her with 2,110 directly held shares and 369 RSUs still outstanding from a 492-unit grant made on October 16, 2025. On January 15, 2026, she received an additional 44 shares of common stock in connection with her annual retainer as Chair of the Board, bringing her direct holdings to 2,154 shares.
CACI International Inc. director Debora A. Plunkett reported the vesting of restricted stock units and corresponding issuance of common shares. On January 14, 2026, 84 Restricted Stock Units converted at an exercise price of $0.0000 per unit into 84 shares of CACI common stock, reported as a transaction with code "M." Following this transaction, she directly held 2,648 shares of CACI common stock and 254 Restricted Stock Units.
The footnote explains that on October 17, 2025, she was granted 338 Restricted Stock Units, scheduled to vest in four installments: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Ryan D. McCarthy reported the vesting and settlement of restricted stock units into common stock. On January 14, 2026, 84 Restricted Stock Units (RSUs) converted into 84 shares of CACI common stock at a reported price of $0.00 per share, reflecting a routine equity award vesting.
These RSUs were part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four tranches: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026. After this transaction, McCarthy directly beneficially owned 2,153 shares of CACI common stock and 254 RSUs, all reported as directly held.
CACI International Inc. director David F. Keffer filed an initial ownership report on Form 3. The filing states that, as of the event date of 01/01/2026, he beneficially owns no securities of CACI International Inc. This confirms his role as a director while disclosing that he holds no direct or indirect equity or derivative positions in the company’s stock.
CACI International Inc reported changes to its board of directors. On December 24, 2025, William L. Jews informed the company he will resign from the board effective December 31, 2025, and his resignation is stated not to result from any disagreement regarding the company’s operations, policies, or practices.
On December 29, 2025, the board appointed Michael Gilday and David Keffer as directors effective January 1, 2026, filling the vacancies created by Mr. Jews’ resignation and the earlier passing of director Michael A. Daniels. The board determined both new directors meet New York Stock Exchange independence requirements and are independent of the company. They will serve initial terms expiring at the next annual meeting of shareholders, receive the standard non‑employee director compensation, and there are no related‑party arrangements requiring disclosure.